INNOVIVA, INC. Other Current Liabilities
INNOVIVA, INC. (INVA) had Other Current Liabilities of $17.13 million as of 2024-06-30, per its 10-Q filed 2024-07-31.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:OtherLiabilitiesCurrent · last filed 2024-07-31
- 2024-06-30: Other Liabilities, Current $17.13M.
- 2024-03-31: Other Liabilities, Current $23.75M.
- 2023-12-31: Other Liabilities, Current $19.70M.
- 2023-09-30: Other Liabilities, Current $24.70M.
| Period end | Other Liabilities, Current |
|---|---|
| 2024-06-30 | $17.13M 10-Q · filed 2024-07-31 |
| 2024-03-31 | $23.75M 10-Q · filed 2024-05-08 |
| 2023-12-31 | $19.70M 10-Q · filed 2024-07-31 |
| 2023-09-30 | $24.70M 10-Q · filed 2023-11-01 |
| 2023-06-30 | $22.50M 10-Q · filed 2023-08-02 |
| 2023-03-31 | $24.90M 10-Q · filed 2023-05-09 |
| 2022-12-31 | $21.21M 10-K/A · filed 2024-03-05 |
| 2022-09-30 | $15.12M 10-Q · filed 2022-11-09 |
| 2022-06-30 | $17.14M 10-Q · filed 2022-07-27 |
| 2022-03-31 | $8.07M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $1.01M 10-K · filed 2023-02-28 |
| 2021-09-30 | $880.00K 10-Q · filed 2021-10-27 |
| 2021-06-30 | $800.00K 10-Q · filed 2021-07-29 |
| 2021-03-31 | $1.47M 10-Q · filed 2021-04-28 |
| 2020-12-31 | $1.40M 10-K/A · filed 2022-03-17 |
| 2020-09-30 | $1.22M 10-Q · filed 2020-10-28 |
| 2020-06-30 | $776.00K 10-Q · filed 2020-07-29 |
| 2020-03-31 | $734.00K 10-Q · filed 2020-04-29 |
| 2019-12-31 | $562.00K 10-K · filed 2021-02-25 |
| 2019-09-30 | $1.01M 10-Q · filed 2019-10-30 |
| 2019-06-30 | $1.39M 10-Q · filed 2019-07-24 |
| 2019-03-31 | $1.26M 10-Q · filed 2019-05-01 |
| 2018-12-31 | $955.00K 10-K · filed 2020-02-19 |
| 2018-09-30 | $865.00K 10-Q · filed 2018-10-31 |
| 2018-06-30 | $909.00K 10-Q · filed 2018-07-26 |
| 2018-03-31 | $918.00K 10-Q · filed 2018-05-04 |
| 2017-12-31 | $1.50M 10-K · filed 2019-02-19 |
| 2017-09-30 | $1.16M 10-Q · filed 2017-11-03 |
| 2017-06-30 | $2.46M 10-Q · filed 2017-08-08 |
| 2017-03-31 | $3.18M 10-Q · filed 2017-05-05 |
| 2016-12-31 | $1.09M 10-K · filed 2018-02-23 |
| 2016-09-30 | $1.73M 10-Q · filed 2016-11-03 |
| 2016-06-30 | $1.39M 10-Q · filed 2016-08-04 |
| 2016-03-31 | $1.69M 10-Q · filed 2016-05-05 |
| 2015-12-31 | $2.22M 10-K · filed 2017-02-28 |
| 2015-09-30 | $2.46M 10-Q · filed 2015-11-05 |
| 2015-06-30 | $1.79M 10-Q · filed 2015-08-06 |
| 2015-03-31 | $1.69M 10-Q · filed 2015-05-08 |
| 2014-12-31 | $2.11M 10-K · filed 2016-02-24 |
| 2014-09-30 | $3.77M 10-Q · filed 2014-11-04 |
| 2014-06-30 | $4.83M 10-Q · filed 2014-08-07 |
| 2014-03-31 | $4.79M 10-Q · filed 2014-05-07 |
| 2013-12-31 | $4.14M 10-K · filed 2015-02-27 |
| 2013-09-30 | $3.09M 10-Q · filed 2013-11-01 |
| 2013-06-30 | $4.70M 10-Q · filed 2013-08-01 |
| 2013-03-31 | $2.68M 10-Q · filed 2013-05-01 |
| 2012-12-31 | $2.07M 10-K · filed 2014-03-03 |
| 2012-09-30 | $1.83M 10-Q · filed 2012-10-31 |
| 2012-06-30 | $2.08M 10-Q · filed 2012-08-01 |
| 2012-03-31 | $1.97M 10-Q · filed 2012-05-02 |
| 2011-12-31 | $1.95M 10-K · filed 2013-02-26 |
| 2011-09-30 | $1.84M 10-Q · filed 2011-11-02 |
| 2011-06-30 | $1.94M 10-Q · filed 2011-08-03 |
| 2010-12-31 | $2.01M 10-K · filed 2012-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ArriVent BioPharma, Inc. (AVBP) | United States | $1.485B | -10.25 |
| Ultragenyx Pharmaceutical Inc. (RARE) | United States | $1.456B | -5.62 |
| OMEROS CORP (OMER) | United States | $1.456B | 5.50 |
| ANAPTYSBIO, INC (ANAB) | United States | $1.546B | -60.20 |
| Kailera Therapeutics, Inc. (KLRA) | United States | $1.552B | |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |
| Oric Pharmaceuticals, Inc. (ORIC) | United States | $1.367B | -8.00 |
| Rapport Therapeutics, Inc. (RAPP) | United States | $1.623B | -14.56 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |